Award type, scope, and amount
Award type is BPA CALL for MAVACAMTEN (CAMZYOS) and POMALIDOMIDE (POLMALYST), with action date Aug 2, 2026 and current award amount $300000.
Federal award
Award ID 36C24526N0776 | Action date Aug 2, 2026 | NAICS 325412 | PSC 6505
Department of Veterans Affairs recorded a $300,000 bpa call to Bristol-Myers Squibb Company on Aug 2, 2026. The source record describes the award as "MAVACAMTEN (CAMZYOS) AND POMALIDOMIDE (POLMALYST)". GovSpendTrail links this record to its public USAspending.gov record for verification.
This Department of Veterans Affairs award (BPA CALL) was issued on Aug 2, 2026 to BRISTOL-MYERS SQUIBB COMPANY for MAVACAMTEN (CAMZYOS) and POMALIDOMIDE (POLMALYST). The record lists a current award amount of $300,000 and identifies NAICS 325412 and PSC 6505. No linked subaward records are currently shown for this award.
Award type is BPA CALL for MAVACAMTEN (CAMZYOS) and POMALIDOMIDE (POLMALYST), with action date Aug 2, 2026 and current award amount $300000.
Awarding and funding agency are listed as Department of Veterans Affairs; recipient is BRISTOL-MYERS SQUIBB COMPANY (UEI UFGKB2B71N12).
Procurement classification includes NAICS 325412 and PSC 6505. No linked subaward records are currently shown (subaward count 0; subaward amount 0).
GovSpendTrail is independent and not a government website. Always verify records against the linked source system before business, legal, or compliance decisions.